Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

Overview of attention for article published in Patient preference and adherence, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 1 news story.

Galcanezumab has been associated with high patient satisfaction, lower healthcare resource utilization for migraine, and…